Market Place
Sourcing Support
Oculis to Present Privosegtor Data at Summit 2026
11 Jun 2026 //
GLOBENEWSWIRE
Oculis Publishes Managerial Transaction Notifications
10 Jun 2026 //
GLOBENEWSWIRE
Oculis to Participate in Goldman Sachs Healthcare Conference 2026
08 Jun 2026 //
GLOBENEWSWIRE
Oculis` Eye Drops For Diabetic Macular Edema Flunk Phase 3 Test
01 Jun 2026 //
ENDPOINTS
Oculis: OCS-01 Phase 3 DIAMOND Results in Diabetic Macular Edema
29 May 2026 //
GLOBENEWSWIRE
Oculis Discloses Transactions by Managerial Persons
29 May 2026 //
GLOBENEWSWIRE
Oculis Publishes Managerial Transaction Notifications
28 May 2026 //
GLOBENEWSWIRE
Oculis Publishes Managerial Transactions Notification
15 May 2026 //
GLOBENEWSWIRE
Oculis Elects Gregory D. Perry to Board at 2026 AGM
14 May 2026 //
GLOBENEWSWIRE
Oculis Reports Q1 2026 Results, Updates Company Outlook
11 May 2026 //
GLOBENEWSWIRE
Oculis To Present At ARVO Annual Meeting
01 May 2026 //
FIRSTWORD PHARMA
Oculis Publishes Invitation To The Annual General Meeting
21 Apr 2026 //
GLOBENEWSWIRE
Oculis Completes Last Patient Visit in Phase 3 DME Trial
20 Apr 2026 //
GLOBENEWSWIRE
Oculis Discloses Executive Transaction Notifications
08 Apr 2026 //
GLOBENEWSWIRE
Oculis To Participate In Upcoming Investor Conferences
07 Apr 2026 //
GLOBENEWSWIRE
Oculis Gets EMA PRIME for Privosegtor in Optic Neuritis
31 Mar 2026 //
GLOBENEWSWIRE
Oculis Reports Managerial Transactions Notifications
27 Mar 2026 //
GLOBENEWSWIRE
Oculis To Present At North American Neuro-Ophthalmology Society
16 Mar 2026 //
GLOBENEWSWIRE
Oculis Issues Managerial Transaction Notices
16 Mar 2026 //
GLOBENEWSWIRE
Oculis Publishes PDMR Transaction Notifications
13 Mar 2026 //
GLOBENEWSWIRE
Oculis Reports Managerial Transactions Notifications
11 Mar 2026 //
GLOBENEWSWIRE
Oculis Reports Managerial Transactions Notifications
06 Mar 2026 //
GLOBENEWSWIRE
Oculis To Participate In Upcoming Investor Conferences
05 Mar 2026 //
GLOBENEWSWIRE
Oculis Publishes 2025 Consolidated Financial Statements
05 Mar 2026 //
GLOBENEWSWIRE
Oculis Reports Managerial Transactions Notifications
04 Mar 2026 //
GLOBENEWSWIRE
Oculis Reports 2025 Financial Results And Company Update
03 Mar 2026 //
GLOBENEWSWIRE
Oculis Reports Managerial Transactions Notifications
27 Feb 2026 //
GLOBENEWSWIRE
Oculis Publishes PDMR & PCA Transaction Notices
18 Feb 2026 //
GLOBENEWSWIRE
Oculis Appoints Katie Kazem As Chief Legal Officer
17 Feb 2026 //
GLOBENEWSWIRE
Oculis To Present Late-Stage Pipeline In Neuro-Ophthalmology
08 Jan 2026 //
GLOBENEWSWIRE
Oculis Receives FDA Breakthrough Designation For Privosegtor
06 Jan 2026 //
GLOBENEWSWIRE
Oculis Publishes PDMR Transaction Notifications
05 Jan 2026 //
GLOBENEWSWIRE
Oculis Reports Managerial Transactions Notifications
09 Dec 2025 //
GLOBENEWSWIRE
Oculis Reports Managerial Transactions Notifications
03 Dec 2025 //
GLOBENEWSWIRE
Oculis Reports Managerial Transactions Notifications
28 Nov 2025 //
GLOBENEWSWIRE
Oculis Issues Managerial Transaction Notices
18 Nov 2025 //
GLOBENEWSWIRE
Oculis Reports Q3 2025 Financial Results And Company Update
10 Nov 2025 //
GLOBENEWSWIRE
Oculis To Participate In Upcoming November Investor Conferences
05 Nov 2025 //
GLOBENEWSWIRE
Oculis Announces Oversubscribed $110 Million Financing
30 Oct 2025 //
GLOBENEWSWIRE
Oculis Showcases Late-Stage Pipeline At Eyecelerator & AAO 2025
14 Oct 2025 //
GLOBENEWSWIRE
Oculis Reports Managerial Transactions Notifications
14 Oct 2025 //
GLOBENEWSWIRE
Oculis Reports Managerial Transactions Notifications
08 Oct 2025 //
GLOBENEWSWIRE
Oculis Advances Privosegtor To Registrational In Optic Neuritis
06 Oct 2025 //
GLOBENEWSWIRE
Oculis Reports Managerial Transactions Notification
26 Sep 2025 //
GLOBENEWSWIRE
Oculis Presents Phase 2 Acuity Trial Results With Privosegtor
22 Sep 2025 //
GLOBENEWSWIRE
Oculis Announces Transactions by Managerial Personnel
09 Sep 2025 //
GLOBENEWSWIRE
Oculis, EURETINA Unveil Ramin Tadayoni Award 2025 Winner
04 Sep 2025 //
GLOBENEWSWIRE
Oculis to Present DME, Optic Neuritis Trial Data at Meetings
01 Sep 2025 //
GLOBENEWSWIRE
Oculis to Participate in Upcoming September Investor Conferences
28 Aug 2025 //
GLOBENEWSWIRE
Oculis Appoints Global Neuro-Ophthalmology, Retina Experts
25 Aug 2025 //
GLOBENEWSWIRE
Oculis Announces Q2 2025 Financial Results and Company Update
21 Aug 2025 //
GLOBENEWSWIRE
Oculis to Join H.C Wainwright`s Ophthalmology Virtual Conference
12 Aug 2025 //
GLOBENEWSWIRE
Oculis Upsized Loan Facility to Access up To CHF 100 Million
01 Aug 2025 //
GLOBENEWSWIRE
Oculis Announces Transactions by Managerial Personnel
09 Jul 2025 //
GLOBENEWSWIRE
Oculis Publishes Transactions by Managers
09 Jun 2025 //
GLOBENEWSWIRE
Oculis Publishes Results of 2025 Annual General Meeting
05 Jun 2025 //
GLOBENEWSWIRE
Oculis Publishes Transactions by Managers
03 Jun 2025 //
GLOBENEWSWIRE
Oculis to Participate in Upcoming June Investor Conferences
03 Jun 2025 //
GLOBENEWSWIRE
Oculis Publishes Invitation to the Annual General Meeting
09 May 2025 //
GLOBENEWSWIRE
Oculis Reports Q1 Financial Results and Provides Company Update
08 May 2025 //
GLOBENEWSWIRE
